Archive for the ‘drug recall’ Category

You Could Have a Case Against the Manufacturers of Benicar

Monday, June 27th, 2016


If you have begun to suffer severe illnesses or negative symptoms after taking the drug Benicar, you could have a case against the drug manufacturer. As a personal injury law firm, we know how devastating it can be to take your prescription drugs only to find that instead of making you better, it actually makes you worst. Unfortunately, this is all too common especially since many drugs are being used for new purposes that they were not initially intended for.  As a result, the appropriate drug warnings are not always forthcoming and it is common for people to be prescribed medication before all the side effects are well-known or properly conveyed. This is certainly true in the case of Benicar.

It wasn’t until 2013 that the FDA began requiring drug manufacturers to include warnings regarding intestinal problems on Benicar, Tribenzor, HCT, Azor, and generic brands of these drugs.  Since the drug itself was approved in 2002, there have been millions of prescriptions issued without the proper warnings.  If you are someone that has been impacted by this, call our office to discuss the possibility of filing a lawsuit.

Common Symptoms

Taking Benicar can lead to sprue-like enteropathy which can first appear to be Celiac disease. This condition can lead to diarrhea and sudden or severe weight loss.

Proving Negligence

Hiring an attorney is important because of the need to prove negligence or fault.  We need to demonstrate that you were not given the proper warning and that you were unaware that you could suffer intestinal problems.  Also, we need to show that you have indeed suffered harm, what your medicals have been as a result, and how the side effects of taking Benicar has harmed you.  Then, we need to put this in context of the financial damages you have suffered. This requires time and investigative resources, making it in your best interest to hire an attorney that is familiar with these types of cases. We are and we would be happy to assist you.

Schedule a Consultation

To discuss your case in further detail, learn about how Benicar may be responsible for your symptoms, and talk about next steps, call our office and schedule a free consultation.  At the Garmon Law Firm, we can provide you with the assistance you need.  Our goal is to ensure that you are treated fairly throughout the entire process and that you receive financial compensation to pay for the injuries you have suffered, lost wages, etc.


The Dangers of Using Invokana

Tuesday, June 14th, 2016


Invokana, also known as canagliflozin, is a medication of the gliflozin class or subtype 2 sodium-glucose transport inhibitors that is prescribed for the treatment of type 2 diabetes. In most cases, Invokana helps control high blood sugar when combined with a proper diet and exercise; however, there have been instances in which users suffered from keotacidosis, heart attacks, and/or kidney failure. If you believe this medication is to blame for your hospitalization, a personal injury lawsuit can help you obtain the required compensation to cover your losses.

Invokana Uses

When working correctly, Invokana should help control high blood sugar in order to preserve the kidney from damage and help you avoid blindness, maintain nerve functions, and regulate proper blood circulation. This drug can increase the removal of sugar by your kidneys, but it may also cause additional problems.

Invokana Dangers

The manufacturer of Invokana, Johnson and Johnson, is currently facing lawsuits that state they failed to properly warn patients of the risk of kidney failure, heart attack, amputations, and ketoacidosis, the production of excess blood acids. Without the forewarning of these potential side effects, physicians have been unable to prescribe the medication while including proper monitoring and check ups to ensure patients are not already excessively predisposed to these conditions. With proper warning, patients would have been monitored more closely and could have avoided developing these high-risk medical complications.

Clinical studies have shown that the risk of amputation can be doubled or tripled when taking this medication. Because this medication causes the kidney to release more sugar through urine, there is a higher risk of urinary tract infection associated with using Invokana. When UTIs become common or severe, they may damage the kidneys permanently causing kidney failure.

How We Can Help

Two years after Invokana was approved by the U.S. Food and Drug Administration (FDA), severe side effects like those mentioned above were reported, resulting in the issuance of safety warnings. These revised safety warnings have continued to develop, the last of which occurred in May of 2016 stating that patients taking Invokana have a higher risk of amputation. If you or a loved one have suffered severe side effects associated with Invokana, a personal injury lawsuit can make it possible for you to gain the compensation needed to cover your hospitable bills. Johnson and Johnson is required to warn patients and physicians alike about the risks associated with this medication, and if they had done so immediately, many patients could have avoided injury.

We can develop your case against Invokana manufacturers and help you gain what is due to you. If you believe you have been harmed by taking this medication, contact the Garmon Law Firm to discuss further action.

Prescribed Zofran as an anti-nausea during pregnancy? Did you know that it has now been linked to Birth Defects?

Saturday, May 16th, 2015

If you know of a baby who has a defect and his/her mother took Zofran during pregnancy – be informed. A new batch of suits has been filed against one of the makers of Zofran, GlaxcoSmithKline, following more than 200 reports of birth defects in children who were exposed during the early pregnancy of their mother. Cases were filed in California Superior court on 30 March 2015 which followed others one having been filed in Massachusetts and one in Pennsylvania. Each of these cases allege congenital issues caused by the drug to include hear defects. The prescription of Zofran was given to mother who were experiencing nausea and vomiting associated with being pregnant. The problem is a lack of adequate testing in pregnant mother and the drug was not approved for use in pregnant mothers by the FDA.

The drug manufacturer improperly marketing Zofran to treat pregnancy related nausea and vomiting. These allegations of improperly marketing follow an agreement by Glaxo to settle with the U.S. Department of Justice for a fine of $3 billion for mismarketing other medications says one of the new lawsuits. The settlement with the government included allegations that Glaxo had improperly marketed Zofran to treat morning sickness which is the very same claim now asserted by the plaintiffs.

The University of Colorado, Stanford University, and London’s Royal Free Hospital have all had scientist reveal from research that when taken during pregnancy, Zofran does in fact cross the placenta to reach the developing fetus. This becomes a problem because it remains longer in the body of the unborn child than with the mother given the half-life is longer in the unborn child. Thus, the elimination rate in the unborn child is not as efficient as that in the mother which scientist are alleging has caused the defects. A report in the journal Clinical Pharmcikinetics indicates that the samples taken by 41 women prior to surgical termination of a pregnancy revealed what was believed to be dangers levels by scientist.

If you, a friend or loved one has experienced a birth defect and the mother was taking Zofran during pregnancy, contact our firm. Any birth defect, heart condition or abnormality may have been caused by the medication. Contact us at 256-543-HURT.

If you or a loved one has suffered an injury or died because of the Gardasil vaccine, please feel welcome to contact our office

Thursday, January 8th, 2015

Evidence of credible concerns continues to surface. We thank Dr. Tenpenny, Dr. Dalbergue and Dr. Eisenstein for their dedication to the research and articulation of the serious safety concerns over certain vaccinations.

Read More »

Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication – FDA Investigating Two Deaths Following Injection

Wednesday, June 19th, 2013

AUDIENCE: Health Professional, Pharmacy, Patient

ISSUE: FDA is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate). The patients died 3-4 days after receiving an appropriate dose of the drug, well after the 3-hour post-injection monitoring period required under the Zyprexa Relprevv Risk Evaluation and Mitigation Strategy (REMS). Both patients were found to have very high olanzapine blood levels after death.

BACKGROUND: Under the REMS, patients are required to receive the Zyprexa Relprevv injection at a REMS-certified health care facility, to be continuously monitored at the facility for at least 3 hours following an injection, and to be accompanied home from the facility. The Zyprexa Relprevv label contains warnings about the risk of post-injection delirium sedation syndrome (PDSS), a serious condition in which the drug enters the blood too fast following an intramuscular injection, causing greatly elevated blood levels with marked sedation (possibly including coma) and/or delirium

RECOMMENDATION: FDA is providing this information to health care professionals while it continues its investigation. If therapy with Zyprexa Relprevv is started or continued in patients, health care professionals should follow the REMS requirements and drug label recommendations. Patients and caregivers should talk to their health care professional(s) about any questions or concerns.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online:
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Read the complete MedWatch Safety Alert, including a link to the Safety Communication

Designed & Developed by sleon productions